CFAP92

Across TCGA pan-cancer cohorts, CFAP92 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated CFAP92 data layer compared with 6 for mutation status.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher CFAP92 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CFAP92 expression acts as an unfavorable survival marker, although some lineages such as READ and STAD show a favorable association.

BLCA, LGG, and ACC are the cancer types where CFAP92 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Quartile	All	0.593	0.749	.006	70	view →
LGG	OS	Median	All	0.754	0.864	<.001	44	view →
ACC	DFS	Quartile	IV	0.033	0.434	.003	38	view →
SKCM	OS	Median	All	0.833	0.912	.004	34	view →
MESO	OS	Quartile	All	0.279	0.747	.001	34	view →
UCS	OS	Median	IV	0.404	0.752	.013	30	view →
CHOL	DFS	Median	II,III,IV	0.108	0.512	.009	27	view →
READ	DFS	Median	III,IV	0.852	0.631	.004	23	view →
STAD	OS	Quartile	III,IV	0.760	0.311	.003	12	view →
LUAD	DFS	Tertile	IV	0.390	0.808	.031	12	view →
CESC	OS	Median	III,IV	0.859	0.625	.005	12	view →
ESCA	OS	Median	All	0.577	1.000	.005	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

CFAP92–BLCA (DFS)

Open the BLCA breakdown →